BRIDGE PHARMA

Serial Number 97759618
602

Registration Progress

Application Filed
Jan 18, 2023
Under Examination
Approved for Publication
Published for Opposition
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: BRIDGE PHARMA
Previous Owner: Bridgewest International Holdings LLC
Classes: 042

Trademark Image

BRIDGE PHARMA

Basic Information

Serial Number
97759618
Filing Date
January 18, 2023
Abandonment Date
September 9, 2024
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
602
Status Date
Sep 10, 2024
Classes
042

Rights Holder

Bridgewest International Holdings LLC

16
Address
701 Brickell Avenue, Suite 1490
Miami, FL 33131

Ownership History

Bridgewest International Holdings LLC

Original Applicant
16
Miami, FL

Legal Representation

Attorney
Lisel M. Ferguson

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

25 events
Date Code Type Description Documents
Apr 25, 2025 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Apr 25, 2025 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Apr 25, 2025 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Sep 10, 2024 MAB2 E ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND Loading...
Sep 10, 2024 ABN2 O ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Loading...
Aug 7, 2024 CORV P REVIEW OF CORRESPONDENCE COMPLETE Loading...
Aug 7, 2024 ATRV O ATTORNEY REVIEW COMPLETED Loading...
Aug 7, 2024 DPCC D DIVISIONAL PROCESSING COMPLETE Loading...
May 14, 2024 DRRR I DIVISIONAL REQUEST RECEIVED Loading...
Aug 6, 2024 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Jun 7, 2024 XELG O APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Loading...
Jun 7, 2024 XELR I APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Loading...
May 14, 2024 ERTD I TEAS REQUEST TO DIVIDE RECEIVED Loading...
Mar 7, 2024 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED Loading...
Mar 7, 2024 GNFR O FINAL REFUSAL E-MAILED Loading...
Mar 7, 2024 CNFR R FINAL REFUSAL WRITTEN Loading...
Jan 25, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jan 24, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jan 24, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Oct 25, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Oct 25, 2023 GNRT F NON-FINAL ACTION E-MAILED Loading...
Oct 25, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
Oct 16, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Jan 25, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jan 21, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Scientific research and development of therapeutics, disinfectants, diluents, and vaccines for the treatment of dehydrations, low potassium levels, bleeding, infection and pain

Classification

International Classes
042

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"PHARMA"